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Summary
 
During apoptotic cell death, cell surface ligands initiate phagocytosis of the dying cell. Clear-
ance of these apoptotic cells is thought to occur without an immune response. Since a number
of autoantigens are located at the cell surface or within apoptotic blebs, we examined whether
exposure of mice to syngeneic apoptotic cells by the intravenous route could induce autoanti-
body production. Normal mice injected with syngeneic apoptotic thymocytes developed anti-
nuclear autoantibodies and anticardiolipin and anti-ssDNA antibodies. The autoantibody levels
were generally lower than those observed in MRL/Fas
 
lpr
 
 mice and were transient. Surprisingly,
six out of six immunized mice demonstrated immunoglobulin G deposition in the glomeruli
several months after immunization. These findings indicate that systemic exposure to apoptotic
cells can induce an immune response in normal mice, and may help to explain antigen selec-
tion and initiation of the immune response in diseases characterized by increased rates of apop-
tosis such as AIDS and, possibly, systemic lupus erythematosus.
Key words: apoptosis • autoimmunity • systemic lupus erythematosus • anti-DNA • 
anticardiolipin
 
A
 
poptosis is of basic biomedical interest and is of partic-
ular importance in the pathogenesis of systemic au-
toimmune diseases, as exemplified by Fas and Fas ligand
mutations in mice and humans (for review see reference 1).
It is unclear whether there are primary defects in apoptotic
pathways in cells from patients with systemic lupus erythe-
matosus (SLE), although most patients do not have defec-
tive expression or function of Fas/Fas ligand (1). It has long
been appreciated that DNA and histones are major autoan-
tigens in SLE but only more recently recognized that the
DNA–histone complex, i.e., nucleosomes, are the pre-
ferred targets of autoantibodies (2). Unanswered questions
are how and why nucleosomes and several other intracellu-
lar antigen targets become antigenic in SLE.
One possible explanation for antigen selection is apopto-
sis. During apoptosis, the cell membrane forms cytoplasmic
blebs, some of which are shed as apoptotic bodies. Casci-
ola-Rosen et al. (3) have shown that UV-induced apoptosis
of keratinocytes leads to redistribution of several autoanti-
gens to apoptotic blebs. Phosphatidylserine (PS), an acidic
phospholipid autoantigen (4) that normally resides on the
inside of the cell, flips to the outside of the cell membrane
when the cell undergoes apoptosis (5). Together, these
findings provide a hypothesis for antigen selection in SLE,
viz. that SLE patients respond to PS and a subset of intra-
cellular nucleoproteins translocated to cell surface blebs
during apoptosis. To test whether apoptotic cells could,
under some circumstances be immunogenic, we immu-
nized normal mice with syngeneic apoptotic cells.
 
Materials and Methods
 
Apoptosis Induction and Analysis.
 
Apoptosis of thymocytes was
induced by 
 
g
 
-irradiation (600 rads). Apoptosis was quantitated by
annexin-FITC/propidium iodide (PI) staining and flow cytome-
try (6), and by quantitation of the subdiploid peak after PI stain-
ing (7).
 
Immunization Protocol.
 
C3H-SnJ (C3H), BALB/c, C57BL/6
(B6), and MRL/MpJ-Fas
 
lpr
 
 mice (MRL/
 
lpr
 
) mice were obtained
from The Jackson Laboratory (Bar Harbor, ME). Thymocytes
and splenocytes were prepared from 6–8-wk-old mice as de-
scribed previously (8). The thymocytes were either irradiated to
induce apoptosis as above or lysed by three freeze–thaw cycles.
The thymocyte cell lysates and splenocytes (10
 
7
 
 syngeneic cells
per mouse) were injected intravenously without any further ma-
nipulation. The irradiated thymocytes were incubated in medium
at 37
 
8
 
C for 4 h to allow apoptotic changes to occur and 10
 
7
 
 syn-
geneic cells were injected intravenously per recipient. The injec-
tions were performed weekly for a total of four injections.
 
Immune Response.
 
Serum samples were obtained immedi-
ately before immunization and once every 2 wk after immuni-
zation for up to 30 wk. Antinuclear antibodies (ANAs) were
detected by indirect immunofluorescence on Hep-2 cells or a
mouse T cell line (AE.7). Total serum IgG and IgM, anti-ssDNA,
anticardiolipin (AcL), and rheumatoid factor autoantibodies were
quantified by ELISAs as described previously (8, 9). Sera were di-
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luted 1:50 for the ANA and 1:100 for the autoantibody screens.
Values 
 
.
 
3 SD above the mean derived from syngeneic normal
age-matched controls was considered positive for ELISA. Inhibi-
tion studies for anti-ssDNA and AcL were performed as described
previously (26). Antibodies to protein antigens were tested by
Western blot analysis using cell extracts as well as human recom-
binant Ro/SSA, La/SSB, Sm, and ribosomal P proteins (10, 11).
 
Clinical and Pathological Evaluation.
 
Mice were examined bi-
monthly for clinical signs of disease and for hematuria or pro-
teinuria using N-Multistix SG (Bayer, IN). Histological evalua-
tion of kidneys was performed as previously described (8).
Immunofluorescence was examined using a Nikon microphot-fxa
immunofluorescence microscope. The time (seconds) required for
the photometer to obtain sufficient signal for photography (in-
versely proportional to the intensity of the immunofluorescence
signal) was recorded.
 
Results
 
Normal Mice Injected with Syngeneic Apoptotic Thymocytes
Develop ANAs.
 
Irradiation of thymocytes induced apop-
tosis in 
 
z
 
70% of cells as determined by annexin V staining.
Only a small proportion of the cells were in advanced
stages of cell death as determined by admission of PI (
 
,
 
5%)
or trypan blue (
 
,
 
2%) (data not shown).
To determine whether exposure to large numbers of
syngeneic apoptotic cells could evoke an immune response
in normal mice, we injected 10
 
7
 
 cells per mouse by the in-
travenous route. The majority (12 out of 16) of normal
C3H mice injected with apoptotic cells developed positive
IgM ANAs, and approximately half (8 out of 15) developed
IgG ANAs by 4–6 wk after initial immunization (Table 1
and Fig. 1). Although the ANA patterns were heteroge-
neous, the most common patterns observed were nuclear
rim with speckled intranuclear staining (Fig. 1). Similar re-
sults were obtained by immunization of BALB/c and B6
mouse strains, indicating that these results were not strain
specific. Since nonirradiated thymocytes contained 
 
$
 
10%
annexin-binding cells after isolation (data not shown), sple-
nocytes (
 
,
 
5% annexin positive) rather than thymocytes
were used as a control for these experiments. Few of the
nonimmunized mice or mice immunized with splenocytes
developed ANAs (Table 1).
 
Normal Mice Injected with Syngeneic Apoptotic Thymocytes
Develop anti-ssDNA and AcL Autoantibodies.
 
Most of the
C3H mice injected with apoptotic thymocytes produced
modest titers of anti-ssDNA antibodies of both the IgM
and IgG isotypes (Fig. 2, 
 
A
 
 and 
 
B
 
). Similar results were
seen in BALB/c, and B6 mouse strains (data not shown).
Anti-dsDNA antibodies and rheumatoid factor were not
significantly elevated in comparison to age-matched con-
trol (data not shown).
Compared with the low titers of anti-ssDNA produced
in response to immunization with apoptotic thymocytes,
some C3H mice produced quite striking elevations of AcL
antibodies similar to the autoimmune MRL/
 
lpr
 
-positive
controls (Fig. 2, 
 
C
 
 and 
 
D
 
). As with ANAs and anti-ssDNA,
these responses were either absent or substantially lower in
the control-immunized mice. Similar results were observed
in the other normal strains injected with apoptotic thy-
mocytes, although the frequency of response was slightly
lower (IgM and IgG AcL were positive in 7 out of 9 and 6
out of 9 BALB/c mice and 4 out of 6 and 2 out of 6 B6
mice, respectively). As shown in Fig. 2 
 
E
 
, the increases in
AcL autoantibodies observed 2–4 wk after the first injec-
tion declined by week 10 and, for the most part, returned to
baseline (similar to aged-matched, nonimmunized mice). To
verify that the increases in autoantibody production were
the result of the injection of apoptotic cells, we repeated
the series of four injections with syngeneic apoptotic cells 8
wk after the last injection in the same mice. Re-injection
of apoptotic cells once again induced the autoantibody re-
sponse that declined after week 20 (Fig. 2 
 
E
 
).
Negatively charged phospholipids as well as apoptotic
cells bind to 
 
b
 
-2 glycoprotein I (
 
b
 
-2GPI), an important
cofactor for recognition of AcL antibodies. Since immuni-
zation of mice with xenogenic, but not syngeneic 
 
b
 
-2GPI
induces AcL (9), we repeated these experiments with syn-
geneic apoptotic thymocytes that had no contact with for-
eign serum. The frequency and levels of autoantibodies
produced in these mice were virtually identical to those
described above (data not shown), indicating that the im-
mune response observed was not caused by immunization
with bovine 
 
b
 
-2GPI or other FCS-derived products.
 
The Character of AcL.
 
Since DNA and cardiolipin are
highly charged polyanionic molecules, binding to ssDNA
and AcL could be due to a polyreactive antibody popula-
tion (12). Therefore, we performed cross-absorption ex-
periments with ssDNA and cardiolipin micelles. The anti-
ssDNA and AcL antibodies could be inhibited by 50% with
1–10 
 
m
 
g/ml of cardiolipin micelles or ssDNA, respectively,
indicating that these antibodies have some features in com-
 
Table 1.
 
Number and Percentage of ANA-positive Sera
 
Strain Immunogen IgM ANA IgG ANA
C3H/SnJ Irr-T 12/16 (75) 8/15 (53)
SPL 1/6 (17) 0/6 (0)
Lys-T 2/4 (50) 1/4 (25)
Nil 0/10 (0) 0/10 (0)
BALB/c Irr-T 7/9 (78) 5/9 (56)
SPL 1/3 (33) 0/3 (0)
Lys-T ND ND
Nil 1/10 (10) 1/10 (10)
C57BL/6 Irr-T 4/6 (67) 3/6 (50)
SPL 0/3 (0) 0 (0)
Lys-T ND ND
Nil 0/5 (0) 0/5 (0)
Mice were immunized with irradiated apoptotic thymocytes (
 
Irr-T
 
),
nonapoptotic splenocytes (
 
SPL
 
), a thymocyte lysate (
 
Lys-T
 
), or saline
(
 
Nil
 
). Percentages are shown in parentheses. Representative examples
are shown in Fig. 1. 
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mon with the polyreactive autoantibodies described in au-
toimmune strains of mice.
 
Total Ig Levels and Autoantibodies to Protein Antigens.
 
No significant differences in total IgM concentrations were
observed between mice injected with apoptotic thymocytes
and those injected with splenocytes (data not shown). IgG
concentrations were significantly higher in mice with apop-
totic cells at 6 wk after initial immunization compared with
splenocyte-immunized controls (5.9 
 
6
 
 0.88 and 2.57 
 
6
 
0.50 mg/ml, respectively, 
 
P
 
 
 
,
 
0.004). These findings are
consistent with a modest polyclonal activation of the im-
mune system by the apoptotic cells. Western blot analysis
for antibodies to whole cell extracts (both apoptotic and
nonapoptotic), nuclear extracts, or specific recombinant
autoantigens were negative (data not shown).
 
Clinical Evaluation.
 
No obvious clinical changes were
noted in the immunized mice. Proteinuria did not exceed
1
 
1
 
 (as is seen in normal age-matched controls) and hema-
turia was not detected. Light microscopic evaluation of the
kidney was normal with the exception of occasional mild
mesangial proliferation. IgG deposition was not detected in
the glomeruli of any of the nonimmunized controls or
splenocyte-immunized (
 
n
 
 
 
5
 
 4) mice, but was positive in all
six normal mice injected with apoptotic cells (Fig. 3). Of
note, of three kidneys examined from mice immunized
with thymocyte lysate, all had IgG deposition, although the
staining was of lower intensity. The exposure time (sec-
onds) for each group (
 
n
 
 
 
5
 
 3–7 mice per group) were as fol-
lows: nonimmunized control, 
 
.
 
20; nonimmunized MRL/
 
lpr
 
, 4.1 
 
6
 
 1.5; splenocyte-immunized, 
 
.
 
20; apoptotic cell–
immunized, 7.6 
 
6
 
 0.5; lysate-immunized, 12.4 
 
6
 
 1.0.
 
Discussion
 
An important difference between programmed (apop-
totic) versus accidental/toxic (necrotic) death is that pro-
grammed cell death results in the ordered fragmentation of
the cell leading to rapid phagocytosis by neighboring cells
and/or professional phagocytes without cell activation and
inflammation (13). The major observation reported here is
that administration of apoptotic cells by the intravenous
route is able to induce autoantibodies in normal mice. Au-
toantibody production reflected an immune response to
the immunogen since, after subsidence of autoantibody
levels, repeated administration of apoptotic cells once again
induced circulating autoantibodies. The ability to induce
autoantibodies by the intravenous route indicates that han-
dling of apoptotic cells is not always “silent”.
Nonapoptotic splenocytes and the thymocyte lysate
(which contained 
 
z
 
10% annexin V–positive cells before
lysis) induced only slight increases in autoantibody levels in
this model, suggesting that the production of autoantibod-
ies in response to apoptotic thymocytes could not simply
be explained by exposure to high concentrations of cellular
molecules or to “danger” stimuli released by injection.
Since a high titer of AcL antibodies were also produced
when irradiated thymocytes were prepared in the absence
of fetal bovine serum, a role for heterologous 
 
b
 
-2GPI (9)
can be excluded. These findings indicate that the induction
of anti-ssDNA and AcL antibodies reflects an immune re-
sponse to intact apoptotic cells or apoptotic bodies. At
present, we cannot distinguish whether the lower immune
response observed after injection of the thymocyte lysate
(see also below) was due to contamination by blebs derived
from the apoptotic population of cells or whether both
sources induce an immune response.
The immunogenicity of syngeneic apoptotic cells re-
ported here is surprising. Numerous studies over the years
have shown anti-DNA and other autoantibodies are rarely
Figure 2. Mice injected with apoptotic thymocytes produce anti-
ssDNA and AcL autoantibodies. C3H mice (open circles) were immunized
with saline (Nil), irradiated thymocytes (Irr-T), nonirradiated splenocytes
(SPL), or a lysate from irradiated thymocytes (Lys-T). Sera obtained 2–6
wk after initial injection were tested for anti-ssDNA and AcL autoanti-
bodies by ELISA as described in Materials and Methods. The results of
IgM anti-ssDNA (A), IgG anti-ssDNA (B), IgM AcL (C), and IgG AcL
(D) are shown. Results greater than the mean 1 3 SD (horizontal line) ob-
tained from age-matched controls were regarded as positive. Anti-ssDNA
and AcL levels of 5–6-mo-old MRL/lpr mice (closed circles) are shown for
comparison. The kinetics of IgG AcL antibody production are shown in
E. Six C3H mice were immunized weekly with irradiated thymocytes
(time 0 [left arrow] to wk 4). Starting at wk 12 (right arrow), three of these
mice (closed triangles) were reimmunized weekly and three mice (open tri-
angles) were used as controls. Serum was collected at the times shown and
tested for AcL binding as described in Materials and Methods. 
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generated by immunization with self-antigen unless special
adjuvants and/or a foreign carrier are used concomitantly
(14). Furthermore, injection of antigen by the intravenous
route is thought of as a tolerogenic rather than an immuno-
genic pathway (15). The normal immune system is exposed
to many millions of apoptotic cells per day. However, apop-
tosis occurs predominantly in the central lymphoid organs
such as the thymus and bone marrow, where the clearance
of the cells is remarkably efficient. The products of apop-
totic cells may induce tolerance under these circumstances
due to lack of induction of costimulatory signals.
Several possibilities may explain the induction of autoan-
tibodies in the present study. The quantity of apoptotic ma-
terial injected may have overwhelmed the normal clearance
Figure 3. Immunization with
apoptotic thymocytes results in
IgG deposition in renal glomer-
uli. Kidneys obtained from nor-
mal C3H mice immunized with
apoptotic thymocytes (A and B),
were tested for IgG deposition
by immunofluorescence. Non-
immunized, age-matched C3H
and MRL/lpr mice were used as
a negative (C) and positive (D)
controls.
Figure 1. Injection of apop-
totic cells induces ANAs. Serum
obtained from normal C3H mice
either uninjected (A) or injected
with syngeneic apoptotic cells
(B–D) were tested for ANAs by
indirect immunofluorescence at
a 1:50 dilution, 4–6 wk after the
first injection. The cell lines used
for ANA detection were the T
cell lines, AE.7 (A and B) or
HEP-2 (C and D). These figures
are representative of the results
summarized in Table 1. 
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capacity of macrophages leading to abnormal presentation
to B cells or dendritic cells. Phosphatidylserine is exposed
on the apoptotic cell surface membrane (5) and could pro-
vide signal 1 to potentially autoreactive B cells. Since this
antigen would be multivalent, it may be sufficient to act as a
T cell–independent antigen. It is less clear whether nucleo-
somes and other lupus autoantigens are actually exposed on
the outer surface of apoptotic blebs, although it is possible
that even a small degree of breakdown of the apoptotic
blebs would release nucleosomes resulting in anti-ssDNA
production. A recent study reports that uptake of apoptotic
cells by LPS-stimulated macrophages results in the en-
hanced secretion of IL-10 (16). Although IL-10 is immu-
nosuppressive for T cells and enhances apoptosis of SLE T
cells in vitro (17), it augments B cell activation and is pro-
duced at high concentration in patients with SLE (18).
We also observed partial cross-reactivity between anti-
ssDNA and AcL autoantibodies as has been shown with
certain mAbs derived from MRL/
 
lpr
 
 mice (12), suggesting
that some of the autoantibodies generated may be low af-
finity and polyreactive. The increased production of total
IgG in recipient mice argues that some degree of poly-
clonal B cell stimulation was induced, similar to that ob-
served after exposure of B cells to nucleosomes in vitro
(19). The antibodies induced could also reflect expression
of “natural antibodies”.
Finally, since apoptosis and irradiation are associated
with numerous intracellular alterations, protein modifica-
tion in the apoptotic cell or induction of costimulatory
molecules in the phagocyte could contribute to antibody
production. However, autoantibodies were predominantly
targeted to nonprotein antigens and were transient. The
absence of anti-dsDNA antibodies in this study also argues
that T cell tolerance to nucleosomes is either maintained or
only transiently lost in normal strains of mice.
Although none of the mice in this study developed overt
clinical disease, IgG deposits were consistently found in the
kidneys of mice immunized with apoptotic cells several
months after immunization. Even more surprising, mice
immunized with thymocyte lysates also had glomerular
IgG, although of lower intensity. These findings may be
explained by the deposition of nucleosomes in glomeruli
(20) followed by in situ fixation of anti-ssDNA or polyre-
active antibodies. Alternatively, once low titer anti-DNA
antibodies were induced, antigen–antibody complexes may
have formed in the circulation with subsequent renal depo-
sition. As discussed above, the failure to induce high affin-
ity IgG anti-dsDNA antibodies most likely accounts for the
lack of lupus-like glomerulonephritis in the immunized
mice.
The findings in this study suggest that, in diseases charac-
terized by a continuous source of apoptotic cells in the pe-
ripheral immune system, autoantibodies directed against
phospholipids, ssDNA, and possibly other antigens may be
generated as an immune response. Patients with AIDS have
extensive apoptosis of CD4
 
1
 
 T cells (21) and SLE patients
have lymphopenia as well as evidence for an increased rate
of activation-induced cell death (17, 22, 23). The produc-
tion of anti-ssDNA, AcL, and antibodies to other cell sur-
face antigens that occurs in SLE and HIV infections (24)
may therefore be induced by a mechanism similar to that
described herein. On the other hand, this study also sug-
gests that systemic exposure to normal syngeneic apoptotic
cells is probably not a sufficient explanation for induction
of high titer, high affinity, pathogenic autoantibodies. Addi-
tional immunoregulatory defects are most likely required for
the full induction of systemic autoimmune disorders. It will
be of considerable interest to determine whether an increased
apoptotic load accelerates autoimmunity in mice with ge-
netic defects predisposing to systemic autoimmunity and
whether some autoimmunity susceptibility genes relate to
uptake and/or handling of apoptotic cells.
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